Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -593,267 | -419,824 | -221,677 | -846,422 | -659,579 |
| Depreciation Amortization | 7,349 | 4,224 | 2,246 | 7,855 | 5,394 |
| Accounts payable and accrued liabilities | -538 | 1,599 | 91 | 710 | 2,425 |
| Other Working Capital | 11,182 | 14,193 | -4,365 | 16,811 | 22,826 |
| Other Operating Activity | 96,498 | 66,748 | 58,581 | 238,593 | 217,223 |
| Operating Cash Flow | $-478,776 | $-333,060 | $-165,124 | $-582,453 | $-411,711 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -707 | -694 | -461 | -4,049 | -4,000 |
| Purchase Of Investment | -178,144 | -178,144 | -44,660 | -745,680 | -466,053 |
| Sale Of Investment | 495,000 | 330,000 | 210,000 | 504,364 | 312,364 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 391 | N/A |
| Other Investing Activity | -1,849 | -1,829 | 0 | 391 | 391 |
| Investing Cash Flow | $314,300 | $149,333 | $164,879 | $-244,974 | $-157,298 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 250,000 | 250,000 | N/A | N/A | 0 |
| Common Stock Issued | 0 | 0 | N/A | 677,666 | 394,881 |
| Other Financing Activity | 321 | 199 | 369 | 108 | 10,040 |
| Financing Cash Flow | $250,321 | $250,199 | $369 | $677,774 | $404,921 |
| Exchange Rate Effect | -3 | -17 | 23 | 75 | -13 |
| Beginning Cash Position | 102,542 | 102,542 | 102,542 | 252,120 | 252,120 |
| End Cash Position | 188,384 | 168,997 | 102,689 | 102,542 | 88,019 |
| Net Cash Flow | $85,842 | $66,455 | $147 | $-149,578 | $-164,101 |
| Free Cash Flow | |||||
| Operating Cash Flow | -478,776 | -333,060 | -165,124 | -582,453 | -411,711 |
| Capital Expenditure | -707 | -694 | -461 | -4,049 | -4,000 |
| Free Cash Flow | -479,483 | -333,754 | -165,585 | -586,502 | -415,711 |